Skip to content

FONR

FONAR Corporation

NASDAQ · Healthcare · Medical - Devices · US

$19.09
+0.00%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue105.3M104.4M102.9M98.6M97.6M
Cost of Revenue62.9M61.4M57.7M52.9M50.6M
Gross Profit42.4M42.9M45.1M45.7M47.0M
Operating Expenses
R&D Expense1.8M1.6M1.7M1.6M1.5M
SG&A Expense21.4M29.7M29.4M
General & Admin Expense
Selling & Marketing Expense
Other Expenses9.7M26.9M23.5M
Total Operating Expenses32.9M31.3M28.6M31.0M25.0M
Cost and Expenses95.8M92.8M86.3M83.9M75.6M
Operating Income (EBIT)9.5M11.6M16.5M14.8M22.0M
Non-Operating
Interest Income1.8M2.2M
Interest Expense12.6K25.6K77.0K50.1K346.6K
Net Interest Income1.8M2.1M(77.0K)(50.1K)(346.6K)
Other Non-Op Income/Expense1.8M2.2M2.7M969.3K761.7K
Non-Operating Income (excl Interest)(1.9M)(2.2M)(2.8M)(1.0M)(1.1M)
EBT (Pre-Tax Income)11.4M13.8M19.3M15.8M22.8M
Income Tax Expense2.5M3.1M5.2M3.6M5.5M
Bottom Line
Net Income6.7M8.3M10.6M9.4M12.4M
Earnings from Cont. Ops8.9M10.7M14.1M12.1M17.2M
Earnings from Discont. Ops
Bottom Line Net Income6.4M7.9M10.1M8.9M11.9M
Per Share
Basic EPS$1.01$1.26$1.56$1.35$1.78
Diluted EPS$1.00$1.23$1.53$1.32$1.75
Revenue Per Share$17.08$16.52$16.20$14.84$14.89
Shares
Basic Shares Outstanding6.2M6.3M6.4M6.6M6.6M
Diluted Shares Outstanding6.3M6.6M6.5M6.8M6.7M
Profitability Metrics
EBITDA15.9M18.5M23.9M24.6M27.7M
D&A4.5M4.7M4.6M8.8M4.5M
EBIT11.4M13.8M19.3M15.8M23.1M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026